Molecular Therapy Advances
Издатель: Elsevier · ISSN 3117-387X · 90 статей
- Microdystrophins partially rescue deficits of Duchenne muscular dystrophy iPSC-cardiomyocytes
- Deciphering Mechanisms of Feeder Cell-Induced NK Cell Activation to Inform Development of Feeder-Free Expansion Systems
- Safe and efficacious gene therapy for sialidosis: From monocistronic to bidirectional AAV vectors encoding Neu1 and Ctsa
- Combination in vivo HSPC gene therapy for HIV by CCR5 knockout and decoy receptor
- Reproductive safety and germline transmission risk of onasemnogene abeparvovec following i.v. or i.c.v. administration in mice
- PMD: A Geometric Coordinate for Clonal Dominance in Gene and Cell Therapy
- Programmable Transcriptional Activation in Human iPSC-Derived Hepatocyte Metabolic Stress Culture for Target Discovery
- AAV6-Gsx1 promotes sustained functional recovery in a pilot long-term study after contusion spinal cord injury
- A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in mice
- An integrated enzymatic and computational pipeline for quantifying off-target base-editing
- Assessing Germline Transmission Risk and First-in-Human Dose Selection for In Vivo Gene Therapies
- A dual-function adenoviral system for transgene delivery and gene editing for host factor studies in a murine model of SARS-CoV-2 infection
- A Novel Human iPSC-derived Liver Model for In Vitro Assessment of AAV Gene Therapies
- Cryo-EM Mapping of Human Neutralizing Antibodies Reveals 3-fold Antigenic “Hotspot” on the AAV2 Capsid
- Validation of an agonistic canine anti-CD3ε antibody for the production of metabolically fit T cells for adoptive therapy
- A Streamlined AAV Purification Process via Engineered Affinity Tag-Assisted Liquid-Liquid Phase Separation
- Neutralizing antibodies against 20 different AAV variants are rare in human cerebrospinal fluid despite high seroprevalences.
- A Parametric Study of AAV-PHP.eB for CNS Gene Transfer in C57BL/6J Mice: Transduction Kinetics, Safety Profiles, and Applications
- From GMP manufacture of CellThRPE1 to regulatory authorisation of a First-in-Human Phase I clinical trial in geographic atrophy
- Automated Ex Vivo Processing Enables Lentiviral Transduction and Preserves Stemness in Human CD34+ Hematopoietic Stem and Progenitor Cells
- Postnatal gene restoration in succinic semialdehyde dehydrogenase deficiency (SSADHD) reveals phenotype reversibility
- AAV9-PMM2 therapy rescues neuronal phenotypes in a human cortical organoid model of PMM2-CDG
- The antileukemic efficacy of CAR-NK cells is shaped by clonal expression of inhibitory KIRs and patient-encoded KIR ligands
- Decoupling Efficacy from Toxicity: Engineering Spatial Control in AAV-Mediated Gene Therapy
- Clinical immunogenicity in rAAV gene therapy: Insights and implications
- Stealthy lentiviral vectors: Breaking the barriers to systemic in vivo gene delivery
- AAV serotype IVDs for patient selection in gene therapy development: Technical and regulatory considerations by ARDAT consortium
- SGLT1 inhibition in cystic fibrosis: From preclinical evidence to clinical potential
- Baculovirus helper functions during recombinant adeno-associated virus production in insect cells for gene therapy applications
- Management of acute infusion-related reactions in AAV gene therapy guided by mechanistic insight